Japanese drugmaker Eisai Co Ltd said on Saturday it had submitted an application to the U.S. Food and Drug Administration for a standard review of its Alzheimer's drug Leqembi, which was recently approved under the agency's accelerated review process.
Kevin McCarthy wakes up on Saturday morning with a long-held dream fulfilled: After a four-day standoff, he was elected speaker of the U.S. House of Representatives, becoming the most powerful member of the Republican Party.
The S&P 500 pared some gains in volatile trading on Wednesday, after minutes from the Federal Reserve's last meeting showed that while officials agreed to slow the pace of interest rate hikes, they were still laser-focused on controlling inflation.
(Reuters) -Wall Street's main indexes reversed early losses on Wednesday, as investors looked past a set of economic data, with focus squarely on the Federal Reserve's December meeting minutes for clues on the outlook for interest rates.
China receives US equipment to make advanced chips despite new rules - report
China receives US equipment to make advanced chips despite new rules-report
U.S. Treasury yields have peaked, say strategists for fourth straight month: Reuters poll
Google's expert in US antitrust trial defends billions paid to device makers
Post-strike Hollywood rushes to get film, TV sets humming
